{
    "organizations": [],
    "uuid": "576a48057ea835422f0d55ef6ede1d916c84a321",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hangzhou-tianmushan-pharmaceutical/brief-hangzhou-tianmushan-pharmaceutical-enterprise-unit-obtains-high-tech-enterprise-recognition-again-idUSL4N1P62ZH",
    "ord_in_thread": 0,
    "title": "BRIEF-Hangzhou TianMuShan Pharmaceutical Enterprise unit obtains high-tech enterprise recognition again",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd\n* Says Huangshan-based pharmaceutical unit was recognized as high-tech enterprise again and could enjoy a tax preference of 15 percent, from 2017 to 2019\nSource text in Chinese: goo.gl/z6tm3b\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T16:32:00.000+02:00",
    "crawled": "2018-01-12T18:35:25.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "hangzhou",
        "tianmushan",
        "pharmaceutical",
        "enterprise",
        "co",
        "ltd",
        "say",
        "pharmaceutical",
        "unit",
        "recognized",
        "enterprise",
        "could",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}